Proton Pump Inhibitors - CME Conferences
Proton Pump Inhibitors - CME Conferences
Proton Pump Inhibitors - CME Conferences
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
6 th Annual Primary Care Spring Conference Thursday, April 12, 2012<br />
FDA Requirements for Generic<br />
Ophthalmics<br />
• The following companies that offer generic latanoprost in<br />
the same formula as Xalatan include:<br />
– Brand Xalatan by Pfizer - $81.85 AWC/2.5ml 0.005% soln<br />
– Bausch + Lomb - $13.43 AWC/2.5ml 0.005% soln<br />
– Falcon Pharmaceuticals Ltd., an affiliate of Alcon Laboratories,<br />
Inc. (owned by Novartis) - $10.00 AWC/2.5ml 0.005% soln<br />
– Apotex Corp. - $53.12 AWC/2.5ml 0.005% soln<br />
– Greenstone LLC (owned by Pfizer) - $13.38 AWC/2.5ml 0.005%<br />
soln<br />
– Mylan – $6.90 AWC/2.5ml 0.005% soln<br />
– Note that all of the above have FDA Therapeutic Equivalent<br />
Codes of AT and are considered by the FDA therapeutically<br />
equivalent<br />
FDA Orange Book for Solutions<br />
• All solutions and DESI drug products containing the<br />
same active ingredient in the same topical dosage<br />
form for which a waiver of in vivo bioequivalence has<br />
been granted and for which chemistry and<br />
manufacturing processes are adequate to<br />
demonstrate bioequivalence, are considered<br />
therapeutically equivalent and coded AT.<br />
Pharmaceutically equivalent topical products that<br />
raise questions of bioequivalence, including all post-<br />
1962 non-solution topical drug products, are coded<br />
AB when supported by adequate bioequivalence<br />
data, and BT in the absence of such data.<br />
41<br />
Wayne Weart, Pharm D<br />
Cost Effective Rx